Intratus

Intratus is a privately held, clinical-stage life sciences company dedicated to developing its proprietary, novel non-invasive drug technologies. Intratus’ portfolio focuses on the treatment of numerous ophthalmic diseases. Additionally, the platform technology extends to systemic conditions such as cardiovascular disease, diabetes, allergies, and immunology. Intratus' mission is to bring innovative drug delivery technologies to patients.